We report the unusual case of a 72-year-old man who developed acute and extensive necrosis of the nasa l skin and soft-t issue envelope while undergoing chemotherapy for Waldenstrom smacroglobulinemia,alymphoproliferative disorder: The pa tient's treatment involved infu sions of rituxitnab, a chimeric monoclonal antibody that is directed against B cell surface membran e protein CD20. The patient refu sed surgery to restore the nose, and he was treated conservatively with wet-to-dry dressings and antibiotic ointment.Approximately5 weeks after admission, the eschar had exfoliated, revealing that the underlying skin was pink and healthy; no significant areas ofnecrosis remained. Within weeks, the nose had healed completely without scarring. A good aesthetic result was achieved exclusively through healing by secondary intention. We wish to alert the medical community that (1) conservative management of even extensive nasal skin loss should be considered when clinically acceptabl e, and (2) there may be an association between anti-CD20 antibody therapyfo r Waldenstrom smacroglobulinemia and skin necrosis.
Introduction
Nasal recons truction poses a challenge to the facia l plastic surgeo n. The nose is a vital central facial structure, and its aesthetics and funct ion require an optimal treatment algorithm . For the best outcome, three layers should be reconstructed: the internal lining, the bony-cartil aginous skeleton, and the skin. Reconstructive option s for the skin envel ope include seco ndary healin g by granulation and From by placement of split-thickness and full-thickness skin grafts, local rotation/advancement flaps, regional pedicle flaps, and free flaps. Most reconstructi ve surgeons today recommend early initiation of reconstruction. The reasons for this approach include optimization of outcomes and a shorter reco very proce ss. We present an interesting case in which a patient developed skin necrosis of the entire nose. A good aesthetic result was achieved exclusively through healin g by secondary intention.
Case report
A 72-year-old man with a history of Parkinson's disease and newly diagnosed Waldenstrom 's macroglobulinemia was admitted to the hospital after he had unde rgone treatm ent with plasmapheresis and rituximab , a chimeric monoclonal antibody (dose 2 of 4). The indication for admission was unexplained fevers and chills. One week earlier, he had been treated with an initial dose of ritu ximab, and he had not experienced any significant side effects. Upon admission, the patient was pan-cultured, and vancomycin and cefepime therapy was initiated . His hematocrit value was 24.5%, and findings on urinalysis were sig nificant for the presence of many bacteria. His monoclonal IgM level was greater than 5 g/dl.
On hospital day 4, the patient had been afebrile for more than 24 hours, and so the third dose of rituxim ab was infused. After approximately 150 ml of medication had been delivered, the patient developed rigors and his oxygen saturation level fell to 88%. The infusion was stopped immediately, and meperidin e was administered to treat a febrile nonhem olytic reaction. The patient quickly stabilized, and the rituximab infusion was continued. Upon compl etion of the infusion, the patient's fingers and toes had a mottled appearance.
Several hours after the completion of the chemotherapeutic treatment, the patient became acutely hypotensive and cyanotic, and ischemic changes were noted on his nose and digit s. His laboratory values were significant for disseminated intravascular coagulation and acute renal failure. He was urgently transferred to the medical inten sive care unit , and an otolaryngology con sult was requested.
Close inspection of the nose revealed that the overlying skin was edematous and violaceous. The nose was tender to palpation . No acti ve bleeding em anated from the nasal cavity, but clot s were noted bilaterally. Ulce ration and ecchymosis were evident over the soft palate, and they extended to the hard palate. Scattered petechiae of the buccal mucosa were seen bilaterally. Flexible diagnostic laryngoscopy performed trans orally revealed the presence of an ecchymotic lesion on the left tip of the epig lottis . The re was no active bleeding of the nasopharynx or oropharynx. The patient was intubated for airw ay protection, and a biop sy of necrotic tissue from the right first digit was performed by the dermatology service. The biopsy findings were significant for thrombotic vascu litis in the small and medium-sized vessel s. Biopsy also revealed some leukocytoclasia that was con sistent with thrombosis secondary to Waldenstrom's macroglobulinemia rather than a septic embolic event.
Over the next week, the patient's overall medical condition improved, and he was successfully extubated. The nasal necrosis had become sharply demarcated along the glabella and the facial-nasal junctions (figure 1). Purple eschar was evident along the dorsum, and it exte nded to the nasal tip. The necrosis was minimally debrided at the bedside. Bedside discu ssion with the patient and his fam ily by the consulting fac ial plastic surgery service included a recommendation for nasal reconstruction with a paramedian forehead flap for coverage. However, the patient and his family refused any surgical intervention, so local wound care with wet-to-dry dress ings and antibiotic ointment coverage was continued.
Approximately 5 weeks after adm ission , the eschar had exfoliated, revealing that the underlying skin was pink and healthy. No significant areas of necrosis remained, although a sma ll anterior nasal septal perforation was noted . The patient's monoclonal IgM concentration had falle n to 1.9 g/dl. Because the need for nasal reconstruction no longer existed, the patient was disc harged to a rehabilitation hospital with follow-up as an outpatient. At the 12-week follow -up, the patient had healed completely without scarri ng (figure 2).
Discussion
The face is divided into aesthetic regions, with the nose being a distinct subunit. Nasal defects up to 15 or 20 mm can often be successfully repaired with local flaps. Larger lesion s may req uire flaps taken from other aesthetic regions . The paramedian forehead flap is commonly used to achieve recon struction of large nasal defects.' Healing through secondary intention has not been widely advocated for large nasal defects that involve multiple nasal subunits, including the nasal tip.
The lesion in our patient was confined to the external nasal epithelium.The underlying cartilage and nasal mucosa rema ined viable, which made the paramedi an forehead flap an appropriate recommendation for recon struction. If our patient's skin loss had extended to the alar margin , a cartilage graft might have been necessary to prevent extern al nasal valve collapse and alar retraction. Fur thermore, if cartilaginous destruction had been present, the specific cartilage subunits would have required recon struction for both functional support and aesthetic considerations.
The paramedian forehead flap is well suited for the recon struction of the nose . The color, texture, and consistency of forehead skin are similar to those of nasal skin. In addition, the flap is a hardy one, owing to its well-vascularized pedicle. The donor site can be clo sed primarily in many cases and by secondary intention when neces sary. The patient is left with an unobtrusive vertical scar that heals in the midline of the forehead . A second procedure is required to detach the ped icle. I Our patient's nasal defect was probably the result of his underlying medical condition and subseq uent treatment. Waldens trom 's macroglobulinemia is a Iymphoproliferative disorder characterized by bone marrow infiltration by small lymphocytes, Iymphoplasmacytic cells, and a monoclon al IgM serum peak.P Most cases of Waldenstrom's macroglobulinemia are diagnosed secondary to a finding of fatigue-related anemi a. Patien ts may also present with lymphadenopathy,splenomegaly,hyperviscosity syndrome , cryoglobulinemia, peripheral neuropathy, cold aggluti nin Obt aining a nasal skin biop sy at the initial presentation would have been helpful in identifying the depth of necro sis early, and perhaps this would have prompted the surgeon to recommend a less aggressive restoration than a full nasal recon struction with a forehead flap . But as it turned out , the unwillingness of the patient and his fami ly to consider such a massive reconstruction spared the patient from what would have been, in retrospect, an unnecessary operation.
In conclusion, conservative management of even extensive nasal skin loss should be considered when clin ically acceptable . Despite an expectation to the contrary, a very good cosmetic outcome may result. A skin biopsy may help to better define the depth of an apparently severe necrosis, thereby assisting the surgeon in assessment and surgical planning. Although the nature of the relationship of the necrosis to anti -CD20 antibody therapy for Walden strom's macroglobulinemia remains unclear, the medical community should be aware of this possible association. Hyperviscosit y syndrome is caused by the binding of positively charged IgM molecules to red blood cells , which in turn lead s to aggregation and ultimately a rouleaux formation of these complexes. As a result, the visco sity ofthe blood Figure 2 . Twelve weeks f ollowing discharge, healin g is complete and the aesthetic result is excellent.
increases secondary to increased prot ein concentration . 3 Most often, patients with hyperviscosity syndrome present with oron asal bleeding, dizz iness , and/or visual disturbances related to retinal bleeding. Reducing the amount of circulating M protein usually leads to the resolution of symptoms, although the relationship between hypervisco sity syndrome and M protein is not fully understood .' Rituximab, the chimeric monoclonal antibody, is directed against B cell surface membrane protein CD20. This agent has been useful in treat ing Waldenstrom 's macroglobulinemia because most affected lymphoplasmacytic cell s express this protein.' > Approved by the Food and Drug Administration in 1997 for use in patients with low -grade or foll icul ar, CD20-po sitive, B cell non-Hodgkin's lymphoma, rituximab has been linked to an exten sive list of reported side effect s, including infusion reactions, tumor lysis syndrome, mucocutaneous reactions , hypersensitivity reactions, cardiac arrhythmias, angina, and ren al failure." Furthermore, it has been shown that this medication can cau se a sudden rise in serum IgM and visco sity level s, thereby placing patients at risk for hyperviscosity syndrom e.'
The true etiology of our patient's nasal ischemia rem ains unclear. However, of all the possibilities, the infu sion of rituximab is the most likely cause, based on the temporal association of this agent with the patient's ischemia of the fingers and toes in add ition to the nose.
Of particular intere st is the remarkable regeneration of the nasal skin that occurred despite minimal intervention. After 4 weeks of local wound care, approximately half of the nasal coverage had reepithelialized, and the remainder of the nose exhibited healthy granulation tissue. After an additional 3-week period, the nose had healed completely by secondary intention with an optimal cosmetic result (the septal perforation remained). It is likely that the nasal skin necro sis wa s not a full -thickness necrosis, as we initi ally presumed; instead, it appears to have invol ved only the outer half of the dermi s. If the necrosis had indeed affected Volume 85, Number 7
